ClinicalTrials.Veeva

Menu

Roux-en-Y Hepaticojejunostomy for Hepatolithiasis With Sphincter of Oddi Laxity

Zhejiang University logo

Zhejiang University

Status

Completed

Conditions

Hepatolithiasis
Sphincter of Oddi Dysfunction

Treatments

Procedure: Roux-en-Y hepaticojejunostomy

Study type

Interventional

Funder types

Other

Identifiers

NCT01459549
ZYYYSOL

Details and patient eligibility

About

Objective: Evaluate the role of Roux-en-Y hepaticojejunostomy (RYHJ) in hepatolithiasis patients with sphincter of Oddi laxity (SOL).

Summary Background Data: Hepatolithiasis poses high risks of residual, recurrence, and re-intervention. SOL significantly impacts this condition. RYHJ has been recommended for hepatolithiasis concomitant SOL but without prospective evidence.

Methods: This is an open-label randomized controlled trial recruiting patients with hepatolithiasis concurrent SOL. Patients were randomly assigned (1:1) to undergo RYHJ or not. The primary endpoint was stone occurrence, including residual and recurrence, within a three-year postoperative period. Secondary endpoints incorporated perioperative and long-term outcomes, like episodes of cholangitis and invasive re-interventions for stones and related complications. The analyses followed the intention-to-treat principle.

Enrollment

129 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. aged between 18 and 80 years
  2. diagnosed with SOL during operation
  3. suitable for a radical surgery including RYHJ
  4. hopeful to clear stones via operation or combined with subsequent choledochoscopy
  5. provided written informed consent
  6. willing to complete a 3-year follow-up

An intraoperative diagnosis of SOL was established if the rhythmic contraction and relaxation of the sphincter of Oddi were not observed under choledochoscope and the flexible choledochoscope (CHF-P20, external diameter, 4.9 mm; Olympus, Tokyo, Japan) could navigate smoothly to the duodenum through the sphincter of Oddi without any pre-dilation interventions.

Exclusion criteria

  1. with imaging evidences of tumor preoperatively
  2. had congenital biliary malformations
  3. had ever received biliary operation abandoning the Oddi sphincter, such as choledochoduodenostomy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

129 participants in 2 patient groups

Control arm
No Intervention group
Description:
The common bile duct will be maintained for bile drainage in the control arm.
Trial arm
Experimental group
Description:
Roux-en-Y hepaticojejunostomy will be performed for bile drainage in the trial arm.
Treatment:
Procedure: Roux-en-Y hepaticojejunostomy

Trial contacts and locations

1

Loading...

Central trial contact

Liang TingBo, MD,PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems